Last reviewed · How we verify
Vaginal estrogen (vaginal-estrogen)
Vaginal estrogen (generic name: vaginal-estrogen) is a 1 gram vaginally for 7 days, followed by 1 gram vaginally twice weekly thereafter drug developed by Pfizer Inc.. It is currently in discontinued development.
1 gram vaginally for 7 days, followed by 1 gram vaginally twice weekly thereafter
Vaginal estrogen is a small molecule modality that is used to treat various conditions, including Polycystic Ovary Syndrome (PCOS), Stress Urinary Incontinence, and Postmenopausal Disorder. It is administered via vaginal route and is classified as a type of estrogen.
At a glance
| Generic name | vaginal-estrogen |
|---|---|
| Sponsor | Pfizer Inc. |
| Drug class | 1 gram vaginally for 7 days, followed by 1 gram vaginally twice weekly thereafter |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Pipeline indications
- Pelvic Organ Prolapse — discontinued
Common side effects
Key clinical trials
- Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopa (Phase 3)
- Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With (Phase 3)
- A Study To Compare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Hea (Phase 1)
- Study Evaluating Potential Drug Interaction Of Bazedoxifene & Premarin In Healthy Postmenopausal Wom (Phase 1)
- Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms (N/A)
- Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse (N/A)
- Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference F (Phase 1)
- Study Evaluating Conjugated Estrogen Cream for Atrophic Vaginitis (Phase 3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vaginal estrogen CI brief — competitive landscape report
- Vaginal estrogen updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about Vaginal estrogen
What is Vaginal estrogen?
How does Vaginal estrogen work?
Who makes Vaginal estrogen?
What is the generic name of Vaginal estrogen?
What drug class is Vaginal estrogen in?
What development phase is Vaginal estrogen in?
Related
- Drug class: All 1 gram vaginally for 7 days, followed by 1 gram vaginally twice weekly thereafter drugs
- Manufacturer: Pfizer Inc. — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing